Best Health acquired Mabiotech, strengthening its position in the in-vitro diagnostics market and expanding its customer base in Morocco and Africa.

Information on the Target

Best Health, a prominent Moroccan firm specializing in the distribution and installation of medical equipment for hospitals and clinics in Morocco and Tunisia, recently acquired Mabiotech. Mabiotech ranks as the third largest distributor of in-vitro diagnostic devices and reagents for public and private medical laboratories. This acquisition marks a significant milestone for Best Health, which operates under Amethis Maghreb Fund I.

Mabiotech offers a comprehensive portfolio of products that cover key specialties in the industry, including immunology, biochemistry, hematology, and microbiology. With longstanding exclusive relationships with top-tier suppliers like Beckman Coulters and a strong reputation for customer service, Mabiotech has solidified its position as a market leader, particularly amplified by the demand for testing solutions during the COVID-19 pandemic.

Industry Overview in Morocco

The healthcare sector in Morocco has been experiencing substantial growth, supported by the government's Health Plan 2025, which aims to expand universal health coverage, enhance healthcare spending, an